Skip to content
Tenfell
Awarded contract
Published 14 Jul 2017

Epoprostenol powder and solvent (pH10.5) for solution for infusion vials

The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’) · United Kingdom

Key facts

Awarded
04 Jul 2017
Contract starts
04 Jul 2017
Contract ends
04 Jul 2019
Procedure
Open procedure (framework)
Buyer type
Health

Awarded to 35 suppliers

SupplierValue
Mercury Pharma Group—
GlaxoSmithKline—
Martindale Pharma—
Aguettant Ltd—
medac GmbH—
Syner-Med (PP) Ltd—
Teva UK Ltd—
Intrapharm Laboratories Ltd—
Aventis Pharma Ltd T/A Sanofi—
Viatris UK Healthcare Ltd—
Bayer plc—
Dexcel Pharma Ltd—
Generics [UK] T/A Mylan—
Kent Pharmaceuticals Ltd—
Sandoz Ltd—
Chiesi Limited—
Baxter Healthcare Ltd—
Bowmed Ibisqus Limited—
Consilient Health Ltd—
Focus Pharmaceuticals Ltd—
Merck Sharp & Dohme UK Ltd—
Pfizer Ltd—
Ranbaxy (UK) Ltd—
Ennogen Healthcare Ltd—
Rosemont Pharmaceuticals Ltd—
Selective Supplies Ltd—
Wockhardt UK Limited—
Accord-UK Ltd—
Aspire Pharma Ltd—
Galen Ltd—
LEO Pharma Ltd—
Morningside Pharmaceuticals Limited—
hameln pharma ltd—
Correvio GmbH—
Rivopharm UK Ltd—

Categories (CPV)

Similar open tenders

About The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on TED archive (UK notices before Brexit) (EU open data (Decision 2011/833/EU)). Always read the original notice before responding.